US2016074296A1PendingUtilityA1
METHOD FOR STRAIGHTENING HUMAN HAIR FIBERS USING HEATING MEANS AND AN a-HYDROXY ACID DERIVATIVE
Est. expiryMay 24, 2026(expired)· nominal 20-yr term from priority
A61K 8/362A61Q 5/04A61K 8/73A61K 8/365A45D 7/06A45D 2/001A61K 2800/24
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention concerns a method for straightening keratinous fibers including: (i) a step of applying on the keratinous fibers a hair straightening composition containing at least one alpha-hydroxy and/or keto acid derivative, the pH of said composition being not more than 9 (ii) a step of increasing the temperature of the keratinous fibers, using heating means, to a temperature ranging between 110 and 250° C.
Claims
exact text as granted — not AI-modified1 - 14 . (canceled)
15 . A process for relaxing human hair fibers, comprising:
applying to the hair fibers a hair-relaxing composition comprising at least one α-hydroxy acid derivative, wherein the pH of the composition is less than or equal to 7, and heating the hair fibers to a temperature ranging from 110° C. to 250°.
16 . A process according to claim 15 , wherein the hair fibers are heated to a temperature ranging from 120° C. to 220° C.
17 . A process according to claim 16 , wherein the hair fibers are heated to a temperature ranging from 140° C. to 220° C.
18 . The process according to claim 15 , wherein the composition is applied to wet hair fibers.
19 . The process according to claim 15 , wherein the hair fibers are partially predried.
20 . The process according to claim 15 , wherein the molar concentration of the at least one α-hydroxy acid derivative is from 2 to 8 M.
21 . The process according to claim 20 , wherein the molar concentration of the at least one α-hydroxy acid derivative is from 4 to 8 M.
22 . The process according to claim 15 , wherein the at least one α-hydroxy acid derivative is chosen from compounds of formula (I):
wherein
R is chosen from OH and NR 3 R 4 , wherein R 3 and R 4 are independently chosen from hydrogen and a linear or branched C 1 -C 4 alkyl optionally substituted with at least one OH radical;
R 1 is chosen from: H, OH, NH 2 , CH 2 —COOH, and a linear or branched C 1 -C 4 alkyl, and
R 2 is chosen from:
H,
COOH,
CHOH—COOH,
CF 3 ,
CH═CH 2 ,
NHCONH 2 ,
a linear, branched or cyclic C 1 -C 8 alkyl optionally substituted with a radical chosen from OH, Cl, NH 2 , COOH, CF 3 , and SCH 3 ; and
a phenyl and benzyl optionally substituted with one OH or OCH 3 radical; or substituted with the radical
or
R 1 and R 2 optionally are taken together to form an oxo radical (═O) or a cyclopropyl, cyclobutyl, hydroxycyclobutyl, cyclopentyl or cyclohexyl ring with the carbon atom that bears them, or the radical
provided that when R 1 is H, then R 2 may also be chosen from a (CHOH) 2 CH 2 OH and (CHOH) 3 CH 2 OH radical,
and the stereoisomers and organic or mineral salts and solvates thereof.
23 . The process according to claim 23 , wherein the compounds of formula (I) are chosen from:
oxalic acid, lactic acid, 1-hydroxy-1-cyclopropanecarboxylic acid, 2-hydroxy-3-butenoic acid, 2-hydroxyisobutyric acid, 2-hydroxy-n-butyric acid, isoserine, glyceric acid, 2-hydroxy-3-methylbutyric acid, 2-hydroxy-2-methylbutyric acid, 2-hydroxyvaleric acid, 4-amino-2-hydroxybutyric acid, 1-hydroxycyclohexanecarboxylic acid, dihydroxyfumaric acid, citramalic acid, tartaric acid, citric acid, 2-hydroxy-4-(methylthio)butyric acid, mandelic acid, 2-hydroxy-3-methylvaleric acid, glyoxylurea, β-imidazolelactic acid, 2-trifluoromethyl-2-hydroxypropionic acid, hexahydromandelic acid, 2-hydroxyoctanoic acid, arabic acid, 3-phenylactic acid, hydroxyphenylglycine, 3-hydroxymandelic acid, 4-hydroxymandelic acid, 2-hydroxynonanoic acid, L-arginic acid, 3-methoxymandelic acid, 4-methoxymandelic acid, 3-(4-hydroxyphenyl)lactic acid, tartronic acid, tartaric acid, β-chloroacetic acid, 1-cyclopentanol-1-carboxylic acid, 1,2-dihydroxycyclobutanecarboxylic acid, 2-ethyl-2-hydroxybutyric acid, α-hydroxyisocaproic acid, α-hydroxycaproic acid, 2-hydroxy-3,3-dimethylbutyric acid, malic acid, hydroxytartronic acid, gluconic acid, lactamide, N-methyllactamide, N-ethyllactamide, N,N-dimethyllactamide, N-2-hydroxyethyllactamide, and the stereoisomers and organic or mineral salts and solvates thereof.
24 . The process according to claim 24 , wherein the compounds of formula (I) are chosen from:
oxalic acid, L-lactic acid, DL-lactic acid, D-lactic acid, malic acid tartaric acid, DL-glyceric acid, arabic acid, gluconic acid, hydroxytartronic acid, lactamide, N-methyllactamide, N-ethyllactamide, N-2-hydroxyethyllactamide.
25 . A kit comprising at least:
a heating apparatus that provides a temperature ranging from 110° C. to 250° C., at least one hair-relaxing composition comprising at least one α-hydroxy acid derivative, wherein the pH of the at least one composition is less than or equal to 7.
26 . A kit according to claim 25 , wherein the hair-relaxing composition comprises at least one α-hydroxy acid derivative chosen from:
oxalic acid,
lactic acid,
1-hydroxy-1-cyclopropanecarboxylic acid,
2-hydroxy-3-butenoic acid,
2-hydroxyisobutyric acid,
2-hydroxy-n-butyric acid,
isoserine,
glyceric acid,
2-hydroxy-3-methylbutyric acid,
2-hydroxy-2-methylbutyric acid,
2-hydroxyvaleric acid,
4-amino-2-hydroxybutyric acid,
1-hydroxycyclohexanecarboxylic acid,
dihydroxyfumaric acid,
citramalic acid,
tartaric acid,
citric acid,
2-hydroxy-4-(methylthio)butyric acid,
mandelic acid,
2-hydroxy-3-methylvaleric acid,
glyoxylurea,
β-imidazolelactic acid,
2-trifluoromethyl-2-hydroxypropionic acid,
hexahydromandelic acid,
2-hydroxyoctanoic acid,
arabic acid,
3-phenylactic acid,
hydroxyphenylglycine,
3-hydroxymandelic acid,
4-hydroxymandelic acid,
2-hydroxynonanoic acid,
L-arginic acid,
3-methoxymandelic acid,
4-methoxymandelic acid,
3-(4-hydroxyphenyl)lactic acid,
tartronic acid,
tartaric acid,
β-chloroacetic acid,
1-cyclopentanol-1-carboxylic acid,
1,2-dihydroxycyclobutanecarboxylic acid,
2-ethyl-2-hydroxybutyric acid,
α-hydroxyisocaproic acid,
α-hydroxycaproic acid,
2-hydroxy-3,3-dimethylbutyric acid,
malic acid,
hydroxytartronic acid,
gluconic acid,
lactamide,
N-methyllactamide,
N-ethyllactamide,
N,N-dimethyllactamide, and
N-2-hydroxyethyllactamide,
stereoisomers and organic or mineral salts and solvates thereof,
or mixtures thereof.
27 . The process according to claim 22 , wherein:
R is OH; R 1 is chosen from: H, OH, CH 2 —COOH, and a linear or branched C 1 -C 4 alkyl; R 2 is chosen from: H, COOH, CHOH—COOH, and a linear, branched or cyclic C 1 -C 8 alkyl optionally substituted with a radical chosen from OH, NH 2 , and COOH.
28 . The process according to claim 27 , wherein:
R is OH; R 1 is chosen from H and OH; R 2 is chosen from H and a linear, branched, or cyclic C 1 -C 8 alkyl radical.
29 . The process according to claim 24 , wherein the compounds of formula (I) are chosen from:
oxalic acid, lactic acid, malic acid, tartaric acid, tartronic acid, gluconic acid, citric acid, 2-hydroxyisobutyric acid, 4-amino-2-hydroxybutyric acid, α-hydroxycaproic acid, and the stereoisomers, organic or mineral salts and solvates thereof.
30 . The process according to claim 29 , wherein the compounds of formula (I) are chosen from:
lactic acid, and α-hydroxycaproic acid.Join the waitlist — get patent alerts
Track US2016074296A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.